ScholarIQanswers from OpenAlex
Max Healthcare
InstitutionResearch output, impact & collaborations
Max Healthcare is a institution indexed in ScholarIQ from OpenAlex.
What is known about Max Healthcare?
ScholarIQrecord summary
Max Healthcare is a research organisation in New Delhi, IN. OpenAlex records 1,939 works and 34,703 citations for it. 600 researchers list it as their most recent affiliation.
How many works does Max Healthcare have?
ScholarIQindexed works
Max Healthcare has 1,939 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Max Healthcare have?
ScholarIQcitation count
Max Healthcare has 34,703 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Max Healthcare?
ScholarIQresearcher count
Max Healthcare has 600 researchers in the ScholarIQ index.
What is the average h-index at Max Healthcare?
ScholarIQavg h-index
Max Healthcare has an average h-index of 43.5 in OpenAlex.
What is the ROR of Max Healthcare?
ScholarIQror
The ROR for Max Healthcare is on the source record.
What is the OpenAlex record for Max Healthcare?
ScholarIQopenalex
The OpenAlex for Max Healthcare is on the source record.
What is the Wikidata of Max Healthcare?
ScholarIQwikidata
The Wikidata for Max Healthcare is on the source record.
Who are the most-cited researchers behind Max Healthcare?
ScholarIQtop researchers by citations
What are the most-cited papers on Max Healthcare?
ScholarIQmost cited works
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andrej Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Mark C. Petrie, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Subodh Verma, Claes Held, David L. DeMets, Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Stuart Pocock, Peter E. Carson, James L. Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann, Waheed Jamal, Karen Kimura, Janet Schnee, Cordula Zeller, Daniel Cotton, Edimar Alcides Bocchi, Michael Böhm, Dong‐Ju Choi, Vijay Chopra, Eduardo Chuquiure‐Valenzuela, Nadia Giannetti, Stefan Janssens, Jian Zhang, José Ramón González‐Juanatey, Sanjay Kaul, Hans‐Peter Brunner‐La Rocca, Béla Merkely, Stephen J. Nicholls, Sergio V. Perrone, Ileana L. Piña, Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie‐France Seronde, Jindřich Špinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faı̈ez Zannad
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Mikhail Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug, Javed Butler, Søren Rasmussen, Melanie J. Davies, G. Kees Hovingh, Dalane W. Kitzman, Marie L.S. Lindegaard, Daniél V. Møller, Sanjiv J. Shah, Marianne Bach Treppendahl, Subodh Verma, Walter P. Abhayaratna, Fozia Ahmed, Vijay Chopra, Justin A. Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Merkely, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Kavita Sharma, Peter van der Meer, Dirk von Lewinski, Dennis Wolf, Mark C. Petrie
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan, Brian Claggett, Pardeep S. Jhund, Akshay S. Desai, Alasdair D Henderson, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Imran Zainal Abidin, Marco A. Alcocer‐Gamba, J. Atherton, Johann Bauersachs, Changsheng Ma, Chern‐En Chiang, Ovidiu Chioncel, Vijay Chopra, Josep Comin-Colet, Gerasimos Filippatos, Cândida Fonseca, Grzegorz Gajos, Sorel Goland, Eva Gonçalvesová, Seok‐Min Kang, Tzvetana Katova, Mikhail Kosiborod, Gustavs Latkovskis, Alex Pui‐Wai Lee, Gerard C.M. Linssen, Guillermo Llamas-Esperón, Vyacheslav Mareev, Felipe A. Martínez, Vojtěch Melenovský, Béla Merkely, Savina Nodari, Mark C. Petrie, Clara Saldarriaga, José Francisco Kerr Saraiva, Naoki Sato, Morten Schou, Kavita Sharma, Richard W. Troughton, Jacob A. Udell, Heikki Ukkonen, Orly Vardeny, Subodh Verma, Dirk von Lewinski, Л. Г. Воронков, Mehmet Birhan Yılmaz, Shelley Zieroth, James Lay‐Flurrie, Ilse van Gameren, Flaviana Amarante, Peter Kolkhof, Prabhakar Viswanathan
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Mikhail Kosiborod, Mark C. Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, G. Kees Hovingh, Dalane W. Kitzman, Daniél V. Møller, Marianne Bach Treppendahl, Subodh Verma, Thomas Jensen, Karoline Liisberg, Marie L.S. Lindegaard, Walter P. Abhayaratna, Fozia Ahmed, Tuvia Ben‐Gal, Vijay Chopra, Justin A. Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Merkely, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Kavita Sharma, Peter van der Meer, Dirk von Lewinski, Dennis Wolf, Sanjiv J. Shah
How much of the research on Max Healthcare is open access?
ScholarIQopen access share
100%OPEN ACCESS